Cohort Study on Treatment of Cardiovascular Diseases With Traditional Chinese Medicine
Trial Snapshot
- Phase
- Not Applicable
- Status
- Recruiting
- Sponsor
- Enrollment
- 20,000
- Locations
- 1
- Primary Endpoint
- All due to readmission
Study Overview
Brief Summary
This is a cohort study performed in patients with cardiovascular diaeases who were treated with oral Chinese medicine and Western medicine. Collect indicators such as the incidence of cardiovascular events, all due to readmission, all due to death. To hospital using clinical samples to detect genomics, proteomics, metabolomics, intestinal flora and sclerotia.To explore the clinical efficacy of Chinese patent medicine in the treatment of cardiovascular diseases, and provide reliable data support for its clinical application.
Study Design
- Study Type
- Observational
- Observational Model
- Cohort
- Time Perspective
- Prospective
Eligibility Criteria
- Sex
- All
- Accepts Healthy Volunteers
- Yes
Inclusion Criteria
- •All patients admitted to the Department of Cardiovascular Medicine at The First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, The Second Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin Chest Hospital, Tianjin Hospital of ITCWM Nankai Hospital and Tianjin Academy of Traditional Chinese Medicine Affiliated Hospital were considered for inclusion in this study, and all Western medical diagnoses were identified and classified according to the International Classification of Diseases, 11th Revision (ICD-11).
Exclusion Criteria
- •No exclusion criteria.
Arms & Interventions
Exposed group
Western medicine treatment with Chinese medicine treatmen
Intervention: Chinese patent medicine (Drug)
Outcomes
Primary Outcomes
All due to readmission
Time Frame: one year
Readmission for cardiovascular events and readmission for other reasons.
Cardiovascular Events Cardiovascular Events Cardiovascular Events
Time Frame: one year
Non-fatal myocardial infarction, non-fatal ischemic stroke, unplanned hemodynamic reconstruction.
All due to death
Time Frame: one year
Cardiac death and death from other causes.
Secondary Outcomes
No secondary outcomes reported
Investigators
Lin Li
researcher
Tianjin University of Traditional Chinese Medicine